Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 58 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 7547759

    Induction of tumor immunity by variants of folate binding protein

    The Board of Regents of the University of Texas System · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  2. US 7538129

    Diazonamide A analog

    The Board of Regents of the University of Texas System · Granted May 26, 2009 · Expires May 21, 2029

    granted

  3. US 7528133

    Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation

    The Board of Regents of the University of Texas System · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  4. US 7524490

    Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site

    The Board of Regents of the University of Texas System · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  5. US 7517895

    Synthetic diazonamides

    The Board of Regents of the University of Texas System · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  6. US 7514095

    Fabrication of drug loaded biodegradable polymer fibers

    The Board of Regents of the University of Texas System · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  7. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  8. US 7507716

    Method for treating pain with prolactin antagonists

    The Board of Regents of the University of Texas System · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

  9. US 7479550

    Amyloid β gene vaccines

    The Board of Regents of the University of Texas System · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  10. US 7473772

    Chimeric GB virus B (GBV-B)

    The Board of Regents of the University of Texas System · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  11. US 7468379

    Inhibition of osteolytic lesions by SRC kinase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  12. US 7455833

    Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  13. US 7452971

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  14. US 7452964

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  15. US 7446182

    Recombinant antibodies for the detection and neutralization of anthrax toxin

    The Board of Regents of the University of Texas System · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted

  16. US 7435755

    CDDO-compounds and combination therapies thereof

    The Board of Regents of the University of Texas System · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted

  17. US 7429616

    Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

    The Board of Regents of the University of Texas System · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted

  18. US 7423015

    Antihelminthic drugs as a treatment for hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted

  19. US 7422738

    Combined cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted

  20. US 7420100

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  21. US 7420030

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  22. US 7413781

    Gels for encapsulation of biological materials

    The Board of Regents of the University of Texas System · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted

  23. US 7410758

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    The Board of Regents of the University of Texas System · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

  24. US 7410950

    Peptides of CaV2.2 that inhibit pain

    The Board of Regents of the University of Texas System · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.